KINIKSA PHARMACEUTICALS INTE (KNSA) Stock Balance Sheet
NASDAQ:KNSA • GB00BRXB0C07
Current stock price
52.8 USD
-1.05 (-1.95%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 165.60M | 183.58M | 107.95M | 122.70M | 122.50M | |||
| Marketable Securities | 248.48M | 60.05M | 98.42M | 67.90M | 59.70M | |||
| Receivables | 15.59M | 41.72M | 21.27M | 20.30M | 4.00M | |||
| Inventories | 54.90M | 26.36M | 31.12M | 21.60M | 3.70M | |||
| Other Current Assets | 42.61M | 20.08M | 17.54M | 10.50M | 6.60M | |||
| Total Current Assets | 527.18M | 331.80M | 276.30M | 243.10M | 196.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 11.75M | 11.04M | 12.66M | 7.00M | 8.40M | |||
| Intangibles | 15.25M | 16.25M | 17.25M | 18.30M | 19.30M | |||
| Other Non-Current Assets | 209.46M | 221.47M | 220.11M | 191.30M | 8.70M | |||
| Total Non-Current Assets | 236.46M | 248.75M | 250.03M | 216.60M | 36.40M | |||
| TOTAL ASSETS | 763.63M | 580.55M | 526.32M | 459.70M | 232.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 115.02M | 82.50M | 46.92M | 33.40M | 41.40M | |||
| Accounts Payable | 2.03M | 2.04M | 8.25M | 7.90M | 1.90M | |||
| Other Current Liabilities | 22.13M | 16.08M | 8.50M | 5.80M | 1.50M | |||
| Total Current Liabilities | 139.18M | 100.62M | 63.67M | 47.10M | 44.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 56.84M | 41.50M | 23.82M | 16.50M | 2.90M | |||
| Total Non-Current Liabilities | 56.84M | 41.50M | 23.82M | 16.40M | 3.00M | |||
| TOTAL LIABILITIES | 196.03M | 142.12M | 87.48M | 63.50M | 47.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -462.14M | -521.14M | -477.95M | -492.00M | -675.40M | |||
| Additional Paid In Capital | 1.03B | 959.72M | 916.76M | 888.10M | 860.50M | |||
| Common Shares | 21.00K | 20.00K | 20.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -25.00K | -163.00K | 6.00K | 0.00 | -100.00K | |||
| Shares Outstanding | 76.29M | 72.52M | 70.46M | 69.70M | 69.10M | |||
| Tangible Book Value per Share | 7.24 | 5.82 | 5.98 | 5.42 | 2.40 | |||
| Total Shareholders' Equity | 567.61M | 438.44M | 438.84M | 396.10M | 185.00M | |||
| TOTAL LIABILITIES AND EQUITY | 763.63M | 580.55M | 526.32M | 459.70M | 232.80M | |||
| Statistics | ||||||||
| Current Ratio | 3.79 | 3.30 | 4.34 | 5.16 | 4.38 | |||
| Return On Assets (ROA) | 7.73% | -7.44% | 2.68% | 39.89% | -67.84% | |||
| Return On Equity (ROE) | 10.40% | -9.85% | 3.21% | 46.29% | -85.36% | |||
| Return On Invested Capital (ROIC) | 8.21% | N/A | N/A | 1.57% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 24.37% | N/A | N/A | 2.92% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 26.28% | N/A | N/A | 3.19% | N/A | |||
All data in USD , ROIC based on taxRate of 0.34